Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemospan vs Voluven for Preventing Hypotension in Hip Arthroplasty
NCT00421200Phase 3Completed
- Sponsor
- Sangart
- Start
- Feb 2007
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of Hemospan in hypotension, sponsored by Sangart. Started Feb 2007; status: completed.
02
Drugs
Hemospan
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT00421200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421200.